93 related articles for article (PubMed ID: 22475516)
1. Steroid profiles as potential biomarkers in patients with urogenital tract cancer for diagnostic investigations analyzed by liquid chromatography coupled to mass spectrometry.
Konieczna L; Bączek T; Belka M; Fel A; Markuszewski M; Struck W; Markuszewski M; Kaliszan R
J Pharm Biomed Anal; 2013 Jan; 73():108-15. PubMed ID: 22475516
[TBL] [Abstract][Full Text] [Related]
2. Advanced assessment of the endogenous hormone level as a potential biomarker of the urogenital tract cancer.
Konieczna L; Belka M; Baczek T; Ruszkowski M; Struck W; Markuszewski M; Kaliszan R; Markuszewski M
Comb Chem High Throughput Screen; 2013 Jul; 16(6):463-72. PubMed ID: 23410040
[TBL] [Abstract][Full Text] [Related]
3. Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers.
Struck W; Siluk D; Yumba-Mpanga A; Markuszewski M; Kaliszan R; Markuszewski MJ
J Chromatogr A; 2013 Mar; 1283():122-31. PubMed ID: 23465127
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic Heterogeneity of Urogenital Tract Cancers Analyzed by Complementary Chromatographic Techniques Coupled with Mass Spectrometry.
Yumba-Mpanga A; Struck-Lewicka W; Wawrzyniak R; Markuszewski M; Roslan M; Kaliszan R; Markuszewski MJ
Curr Med Chem; 2019; 26(1):216-231. PubMed ID: 28990506
[TBL] [Abstract][Full Text] [Related]
5. Altered levels of nucleoside metabolite profiles in urogenital tract cancer measured by capillary electrophoresis.
Szymańska E; Markuszewski MJ; Markuszewski M; Kaliszan R
J Pharm Biomed Anal; 2010 Dec; 53(5):1305-12. PubMed ID: 20719449
[TBL] [Abstract][Full Text] [Related]
6. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
[TBL] [Abstract][Full Text] [Related]
7. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
[TBL] [Abstract][Full Text] [Related]
8. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
Zhu C; Liang QL; Hu P; Wang YM; Luo GA
Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
[TBL] [Abstract][Full Text] [Related]
9. Surface-activated chemical ionization-electrospray ionization source improves biomarker discovery with mass spectrometry.
Sogno I; Conti M; Consonni P; Noonan DM; Albini A
Rapid Commun Mass Spectrom; 2012 May; 26(10):1213-8. PubMed ID: 22499197
[TBL] [Abstract][Full Text] [Related]
10. Determination of anabolic steroids in human urine by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry.
Saito K; Yagi K; Ishizaki A; Kataoka H
J Pharm Biomed Anal; 2010 Sep; 52(5):727-33. PubMed ID: 20236787
[TBL] [Abstract][Full Text] [Related]
11. Analysis of urinary nucleosides. V. Identification of urinary pyrimidine nucleosides by liquid chromatography/electrospray mass spectrometry.
Bond A; Dudley E; Lemière F; Tuytten R; El-Sharkawi S; Brenton AG; Esmans EL; Newton RP
Rapid Commun Mass Spectrom; 2006; 20(2):137-50. PubMed ID: 16331740
[TBL] [Abstract][Full Text] [Related]
12. Assessment of two complementary liquid chromatography coupled to high resolution mass spectrometry metabolomics strategies for the screening of anabolic steroid treatment in calves.
Dervilly-Pinel G; Weigel S; Lommen A; Chereau S; Rambaud L; Essers M; Antignac JP; Nielen MW; Le Bizec B
Anal Chim Acta; 2011 Aug; 700(1-2):144-54. PubMed ID: 21742127
[TBL] [Abstract][Full Text] [Related]
13. Increasing conclusiveness of metabonomic studies by chem-informatic preprocessing of capillary electrophoretic data on urinary nucleoside profiles.
Szymańska E; Markuszewski MJ; Capron X; van Nederkassel AM; Heyden YV; Markuszewski M; Krajka K; Kaliszan R
J Pharm Biomed Anal; 2007 Jan; 43(2):413-20. PubMed ID: 17000071
[TBL] [Abstract][Full Text] [Related]
14. Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Lin WD; Tsai Y; Lin CT; Wang HC; Jeng LB; Lee CC; Lin YC; Lai CC; Tsai FJ
Clin Chim Acta; 2011 Sep; 412(19-20):1861-6. PubMed ID: 21740897
[TBL] [Abstract][Full Text] [Related]
15. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
16. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.
Issaq HJ; Nativ O; Waybright T; Luke B; Veenstra TD; Issaq EJ; Kravstov A; Mullerad M
J Urol; 2008 Jun; 179(6):2422-6. PubMed ID: 18433783
[TBL] [Abstract][Full Text] [Related]
17. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
[TBL] [Abstract][Full Text] [Related]
18. Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis.
Liu L; Li Y; Guan C; Li K; Wang C; Feng R; Sun C
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2817-25. PubMed ID: 20846914
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics in urogenital cancer.
Bujak R; Daghir E; Rybka J; Koslinski P; Markuszewski MJ
Bioanalysis; 2011 Apr; 3(8):913-23. PubMed ID: 21510764
[TBL] [Abstract][Full Text] [Related]
20. Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine.
Cao DL; Ye DW; Zhu Y; Zhang HL; Wang YX; Yao XD
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):166-72. PubMed ID: 21321584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
